Zepteon, Inc. is a privately held corporation founded in 2012 that has developed first in class chromatography resins capable of separating antibodies with specific sugar structures (nonfucosylated) that are more potent against diseases like cancer. This technology enables more effective therapeutics and can reduce cost and dosing requirements.

Biotechnology

Zepteon

Zepteon's headquarters in Boston, MA, United States

Austin W. Boesch

Glen R. Bolton

Ronald Sia

Marc Silver

Maria Grunwald

Tom Ransohoff

Zepteon's Leadership Team includes Glen R. Bolton and 1 others.

About

People (2)

Austin W. Boesch

Glen R. Bolton

Jobs